Trends in the RSV Diagnostics Market 2013-2019

Veröffentlicht von: Future Market Insights
Veröffentlicht am: 07.12.2017 13:44
Rubrik: Gesundheit & Medizin


(Presseportal openBroadcast) - Human respiratory syncytial virus (RSV) is a virus that commonly causes lower respiratory tract infection. Human respiratory syncytial virus infections are acquired during hospital visits. Infants and in young children are more prone to human respiratory syncytial virus (RSV) infection. RSV infections affect lungs and respiratory tract of an individual. In premature babies and children with previous presence of diseases, RSV infections affect heart and immune systems as well resulting in serious illness. Common symptoms of RSV infection include, cold, cough, headache and weakness. Human RSV infection is highly contagious and its mode of transfer is through liquid droplets produced during coughing and sneezing.
Report Overview and TOC @ https://www.transparencymarketresearch.com/rsv-diagnostics-market.html


All the RSV diagnostics tests currently available in the market use sputum and saliva as specimen for detection of RSV infection. Based on the tests used to detect RSV infection, this market is segmented as follows:
Immunofluorescence
Rapid antigen detection test
Cell culture test
Reverse transcriptase polymerase chain reaction (RT-PCR) kits
Serological tests
Others
Request for Broucher @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2080

Many clinics perform antigen detection test for diagnosis of human respiratory syncytial virus infection. In most of the cases, results of antigen detection tests are validated by cell culture tests. Antigen detection testsare 80% to 90% more sensitive than cell culture test for detection of RSV infection. Currently, reverse transcriptase polymerase chain reaction (RT-PCR) kits are also available in the market for the detection of human respiratory syncytial virus. Though serological tests are available in the market, they are less frequently used for routine diagnosis. Furthermore,based on the type of end users, the RSV diagnosis market is segmented as follows:
Hospitals
Physicians’ offices
Commercial labs
Private Labs
For Specific and Customized Requirements @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=2080

Some of the major companies contributing to global RSV diagnostics market are Becton, Dickinson and Company, Abbott Laboratories, Alere, Inc., Quidel Corporation, and Focus Diagnostics, Inc.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
North America
Asia Pacific
Europe
Rest of the World
Pre Book Full Report @ https://www.transparencymarketresearch.com/rsv-diagnostics-market.html?secure=NTIxNS41&type=PB

Firmenportrait:

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature.

Bitte beachten Sie, dass für den Inhalt der hier veröffentlichten Meldung nicht openBroadcast verantwortlich ist, sondern der Verfasser der jeweiligen Meldung selbst. AGB | Haftungsausschluss.